Advanced Search

Technical Analysis for ONPH - Oncology Pharma Inc.

Grade Last Price % Change Price Change
grade F 0.025 0.00% 0.0000
ONPH closed unchanged on Thursday, December 5, 2019, on 16 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical ONPH trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -16.67%

Older signals for ONPH ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
ONPH Chart by TradingView
Basic chart:

Profile

Oncology Pharma Inc. engages in the development, manufacture, and commercialization of oncology therapeutics. It has a letter of intent with NanoSmart Pharmaceuticals Inc. for its drug delivery vehicle that target various types of cancer and other diseases. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
Health Cancer Life Sciences Diseases Pharmaceutical Industry In China Pharmaceuticals Policy Drug Delivery Science And Technology In The People's Republic Of China Pharmacy In China Santaris Pharma

Is ONPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Oct 8 Oncology Pharma Elects Dr. Stefan Gruenwald (MD, PhD) to its Board of Directors
Aug 19 Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
Aug 19 Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide Licence and Co-Devlopent of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
See more ONPH news...

Indicators

Indicator Value
52 Week High 0.1
52 Week Low 0.003
Average Volume 67,655
200-Day Moving Average 0.0000
50-Day Moving Average 0.0324
20-Day Moving Average 0.0312
10-Day Moving Average 0.0284
Average True Range 0.0065
ADX 12.8
+DI 27.7839
-DI 24.2558
Chandelier Exit (Long, 3 ATRs ) 0.0195
Chandelier Exit (Short, 3 ATRs ) 0.0395
Upper Bollinger Band 0.0410
Lower Bollinger Band 0.0214
Percent B (%b) 0.18
BandWidth 62.8205
MACD Line -0.0022
MACD Signal Line -0.0015
MACD Histogram -0.0007
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0325
Resistance 3 (R3) 0.0317 0.0283 0.0313
Resistance 2 (R2) 0.0283 0.0264 0.0288 0.0308
Resistance 1 (R1) 0.0267 0.0252 0.0275 0.0275 0.0304
Pivot Point 0.0233 0.0233 0.0238 0.0238 0.0233
Support 1 (S1) 0.0217 0.0214 0.0225 0.0225 0.0196
Support 2 (S2) 0.0183 0.0202 0.0188 0.0192
Support 3 (S3) 0.0167 0.0183 0.0188
Support 4 (S4) 0.0175